Literature DB >> 17067189

Better analysis for better decisions: facing up to the challenges.

Michael F Drummond, Mark J Sculpher.   

Abstract

Mesh：

Year:  2006        PMID： 17067189     DOI： 10.2165/00019053-200624110-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  12 in total

1.  Unfinished symphony: a tribute to the life and career of Bernie O'Brien (1959-2004).

Authors:  Andrew Briggs; Martin Buxton; Mike Drummond; Ron Goeree; Mark J Sculpher; Andrew R Willan
Journal:  Med Decis Making       Date:  2004 Sep-Oct       Impact factor: 2.583

Review 2.  Information created to evade reality (ICER): things we should not look to for answers.

Authors:  Stephen Birch; Amiram Gafni
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 3.  Economic evaluation and decision making in the UK.

Authors:  Martin J Buxton
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 4.  Pharmacoeconomics and pharmacoepidemiology: curious bedfellows or a match made in heaven?

Authors:  Andrew H Briggs; Adrian R Levy
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 5.  Economic evaluation in the US: what is the missing link?

Authors:  Peter J Neumann; Sean D Sullivan
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 6.  Building bridges between academic research and policy formulation: the PRUFE framework - an integral part of Ontario's evidence-based HTPA process.

Authors:  Ron Goeree; Leslie Levin
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 7.  Economic evaluations in the canadian common drug review.

Authors:  Andreas Laupacis
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 8.  Utility measurement in healthcare: the things I never got to.

Authors:  George W Torrance
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 9.  Analysis sans frontières: can we ever make economic evaluations generalisable across jurisdictions?

Authors:  Mark J Sculpher; Michael F Drummond
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 10.  Using value of information analysis to prioritise health research: some lessons from recent UK experience.

Authors:  Karl P Claxton; Mark J Sculpher
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.